COLUMBUS, Ohio--(BUSINESS WIRE)--Capsa Healthcare, a leading innovator in healthcare delivery solutions for hospitals, long-term care, and retail pharmacy providers, announced the acquisition of Humanscale Healthcare, a designer and manufacturer of flexible technology solutions and computing workstations based in New York, NY. Capsa’s purchase of Humanscale Healthcare is the company’s seventh major brand acquisition in the last 11 years. With 50+ years of product innovation experience, Capsa has grown steadily through a combination of internal development and acquisition of complementary …

[Read more...] about Sale of Humanscale Healthcare Business

Horizon Discovery Divests Animal Models Business to Envigo * Animal model operations to be transferred to Envigo ownership * Divestment in line with Horizon’s corporate strategy to focus on its core markets * Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business * Horizon and Envigo to collaborate on providing CRISPR screening services CAMBRIDGE, England -- November 8, 2019 Horizon Discovery Group plc (LSE: HZD) ("Horizon", “the Company” or “the Group”), a global leader in the application of gene …

[Read more...] about Divestiture of Horizon’s Research Models Business to Envigo

LOS ANGELES, Sept. 13, 2019 /PRNewswire/ -- CBR (Cord Blood Registry), the world's largest newborn stem cell collection and storage company, today announced the asset acquisition of Natera, Inc.'s (NASDAQ: NTRA) Evercord™ newborn stem cell business. The mutually beneficial move brings together two of the industry's most respected newborn stem cell storage companies. "As a pillar of the California Cryobank Life Sciences (CCLS) organization, CBR is built on scientific excellence, leadership, and best-in-class services," said Richard Jennings, California Cryobank Life Sciences, …

[Read more...] about Divestiture of Natera’s Evercord Cord Blood Business to CBR

  HealthGrid is a leader in the rapidly evolving healthcare patient engagement sector. Industry analyst KLAS defines patient engagement as “the process of motivating and enabling patients to participate in their own care with the expectation that, over time, outcomes will improve and costs will be reduced”. HealthGrid’s intelligent patient engagement technology platform enables providers to stay connected with their patients’ pre-care, point of care and post care, keeping them engaged, informed and supported throughout the healthcare continuum. Please refer to the Company’s website for …

[Read more...] about Sale of HealthGrid to AllScripts Healthcare Solutions

Dynex Technologies, headquartered in Chantilly, Virginia, with offices in Hong Kong, Germany and the U.K., pioneered microplate technology more than 60 years ago, and has since delivered a series of cutting edge, best-in-class ELISA processing systems, including the 4-plate DSX, 2-plate DS2 and Agility high throughput systems. Dynex designs each of its products to meet the rigorous demands of the clinical laboratory. Convergence was engaged by Dynex and its financial sponsors to pursue a strategic alternatives for Dynex including a sale of the Company. Convergence worked with management to …

[Read more...] about Sale of Dynex Technologies to Telegraph Hill Partners

Magellan Diagnostics, Inc, headquartered in Billerica, MA pioneered the engineering, development and manufacturing of FDA-cleared products for the testing of blood to diagnose lead poisoning in children and adults. Convergence was engaged by Magellan and its financial sponsors, to pursue a sale of the Company. Convergence worked actively with Chairman Peter Glick and CEO Amy Winslow to craft a strategic marketing plan for the company that leveraged Magellan's historical performance as a market leader in Lead exposure testing while valuing the opportunity created by Magellan's next …

[Read more...] about Sale of Magellan Diagnostics to Meridian Bioscience